The Avastin® biosimilars market is projected to wi..

created a new article

Translate 12 months ago

The Avastin® biosimilars market is projected to witness noteworthy growth over the coming years | #biosimilars market

The Avastin® biosimilars market is projected to witness noteworthy growth over the coming years

In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based therapeutic, were observed to have declined by 25% due to competition from biosimilars, in the United States, Europe, Japan, and other nations where it is approved

The Avastin® biosimilars market is projected to witness noteworthy growth over the coming years

Like

Comment

Share

640